...
首页> 外文期刊>Cancer science. >Long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA‐22/Snail family transcriptional repressor 1 axis
【24h】

Long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA‐22/Snail family transcriptional repressor 1 axis

机译:长度非致RNA转移相关肺腺癌转录物1与Zeste同源物2的增强子合作,通过调节MicroRNA-22 /蜗牛家族转录压力压1轴来促进肝细胞癌发育

获取原文
           

摘要

Metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) is an oncogenic long noncoding RNA that has been found to promote carcinogenesis and metastasis in many tumors. However, the underlying role of MALAT1 in the progression and metastasis of hepatocellular carcinoma (HCC) remains unclear. In this study, aberrantly elevated levels of MALAT1 were detected in both HCC specimens and cell lines. We found that knockdown of MALAT1 caused retardation in proliferation, migration, and invasion both in vivo and in vitro. Mechanistic investigations showed that Snail family transcriptional repressor 1 (SNAI1) is a direct target of microRNA (miR)‐22 and that MALAT1 modulates SNAI1 expression by acting as a competing endogenous RNA for miR‐22. Inhibition of miR‐22 restored SNAI1 expression suppressed by MALAT1 knockdown. Furthermore, MALAT1 facilitated the enrichment of enhancer of zeste homolog 2 (EZH2) at the promoter region of miR‐22 and E‐cadherin, which was repressed by MALAT1 knockdown. Cooperating with EZH2, MALAT1 positively regulated SNAI1 by repressing miR‐22 and inhibiting E‐cadherin expression, playing a vital role in epithelial to mesenchymal transition. In conclusion, our results reveal a mechanism by which MALAT1 promotes HCC progression and provides a potential target for HCC therapy.
机译:转移相关的肺腺癌转录物1(Malat1)是一种致癌长的非分量RNA,已被发现促进许多肿瘤中的致癌和转移。然而,MALAT1在肝细胞癌进展和转移中的潜在作用仍然不清楚。在本研究中,在HCC标本和细胞系中检测到异常升高的MALAT1水平。我们发现Malat1的敲低导致体内和体外增殖,迁移和侵袭的延迟。机械研究表明,蜗牛家族转录阻遏物1(SNAI1)是MicroRNA(MIR)-22的直接靶标,并且MALAT1通过作为miR-22的竞争内源RNA调节SNAI1表达。 MAR-22的抑制抑制了MALAT1敲低抑制的SNAI1表达。此外,Malat1促进了在miR-22和E-cadherin的启动子区的Zeste同源物2(EzH2)的富集,由Malat1敲低压制。通过抑制miR-22并抑制E-cadherin表达,与EZH2,MALAT1与EZH2,MALAT1正面调节SNAI1积极调节SNAI1,在上皮细胞转变中发挥重要作用。总之,我们的结果揭示了MALAT1促进HCC进展的机制,并为HCC治疗提供了潜在的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号